Company Filing History:
Years Active: 2019-2022
Title: Innovations and Contributions of Inventor Monica Gerber
Introduction
Monica Gerber is a notable inventor based in Somerville, MA, whose research and innovations are significantly impacting the fields of medicine and technology. With a total of four patents to her name, Gerber has demonstrated her commitment to advancing medical science and improving patient care through innovative solutions.
Latest Patents
One of Gerber's most recent patents is titled "Cell-penetrating compstatin analogs and uses thereof." This invention relates to cell-penetrating analogs and compositions that can be utilized in treating complement-mediated disorders. These analogs are designed to inhibit complement-mediated damage to cells, tissues, or organs and can also prevent the production or release of biologically active C3 cleavage products.
Another significant patent is "Schedule-based electronic medical record modules, applications, and uses thereof." This invention involves a computer program product aimed at assembling a database comprising electronic medical records (EMRs). This system enables physicians and patients to use applications to confirm disease-related events, facilitating the tracking and recruitment of clinical trial participants through active diagnosis modules (ADMs) comprising schedules of events.
Career Highlights
Monica Gerber has had an impactful career with notable positions at Apellis Pharmaceuticals, Inc. and Zyus Life Sciences US Ltd. Her work in these companies has underscored her role in driving innovation in the pharmaceutical and medical technology sectors.
Collaborations
Throughout her career, Gerber has collaborated with prominent professionals, including Cedric Francois and Pascal Deschatelets. These partnerships have contributed to the development of her patents and innovations, illustrating the importance of teamwork in scientific advancements.
Conclusion
Monica Gerber's contributions through her patents are a testament to her innovative spirit and dedication to enhancing medical research. Her work, particularly in the area of cell-penetrating compstatin analogs and electronic medical record systems, showcases her ability to bridge the gap between technology and healthcare, positioning her as a key figure in the development of effective solutions for complex medical challenges.